Back to Screener

Incyte Corporation - Common Stock (INCY)

NASDAQ Large Cap

Industrials › Services-Commercial Physical & Biological Research

$96.74
Market Cap: $19.3B
Data as of Mar 31, 2026 (TTM)

Price History

Feb 9, 2026 — Jul 6, 2026

Investment Snapshot

  • Trading 51% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 5/9 — moderate financial health
  • Strong ROE of 23.0% with 26.3% net margin
  • Revenue growing at 21% annually

Incyte Corporation - Common Stock (INCY) is a Industrials company operating in Services-Commercial Physical & Biological Research, listed on the NASDAQ , with a market capitalisation of $19.3 billion . Key value metrics: P/E ratio 15.0, P/B ratio 3.44, Piotroski F-Score 5 out of 9 (moderate financial health) .

Value Score

Key Metrics

P/E Ratio
14.97
3.44
EPS
$6.46
Div. Yield
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Industrials stocks →

Incyte Corporation - Common Stock — Fundamental Analysis Summary

Incyte Corporation - Common Stock (INCY) is currently trading 51% above its Graham Number of $63.96, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 15.0x.

On financial health, INCY shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 23.0% (sector average: 5.4%), and manageable leverage with a debt-to-equity ratio of 0.35.

StockPik's composite Value Score for INCY is 96/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

INCY reports a high gross margin of 92.8% (sector average: 18.0%) and a strong operating margin of 30.2%.

INCY shows revenue growing at 21% year-over-year, with earnings growing at 3,845%.

Top Value Stocks in Industrials

Symbol Price P/E Score
CISS $1.79 0.1 100
ARTW $2.63 7.3 100
CRCT $4.46 10.5 100
CENTA $38.43 9.6 100
BOSC $4.32 8.4 100
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
INBX
Next
INDB